---
category: listing
circular_id: d50fb9ed08b6d30f
date: '2025-12-16'
description: Details of listing of 10,03,40,717 equity shares of NEPHROCARE HEALTH
  SERVICES LIMITED with lock-in periods and distinctive number ranges.
draft: false
guid: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={44C74E7D-ABBE-4BA3-8B20-C22534576D03}&noticeno=20251216-56&dt=12/16/2025&icount=56&totcount=66&flag=0
impact: medium
impact_ranking: medium
importance_ranking: medium
justification: New equity listing with significant lock-in provisions affecting over
  10 crore shares across multiple categories including IPO, ESOP, and AIF investors
pdf_url: https://www.bseindia.com/markets/MarketInfo/DownloadAttach.aspx?id=20251216-56&attachedId=0d459b69-b776-4263-91d5-5be52e8fb9dc
processing:
  attempts: 1
  content_hash: 0bc1285044151f8f
  processed_at: '2025-12-16T18:42:35.664488'
  processor_version: '2.0'
  stage: completed
  status: published
published_date: '2025-12-16T14:36:56+00:00'
rss_url: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={44C74E7D-ABBE-4BA3-8B20-C22534576D03}&noticeno=20251216-56&dt=12/16/2025&icount=56&totcount=66&flag=0
severity: medium
source: bse
stocks:
- NEPHROCARE
tags:
- listing
- equity-shares
- lock-in
- ipo
- esop
- aif
title: Listing of Equity Shares of NEPHROCARE HEALTH SERVICES LIMITED
---

## Summary

BSE has listed 10,03,40,717 equity shares of NEPHROCARE HEALTH SERVICES LIMITED. The shares are divided into multiple categories with varying lock-in periods ranging from January 2026 to June 2027. The listing includes shares under lock-in for promoters, investors, and ESOP allocations, as well as shares not under lock-in for IPO public offering and AIF Category II investors.

## Key Points

- Total equity shares listed: 10,03,40,717
- Distinctive number range: 1 to 10,03,40,717
- Multiple lock-in categories with different expiry dates
- Mix of physical (77,640 shares) and demat format
- Includes IPO public shares, ESOP allocations, and AIF Category II investments

## Share Categories and Lock-in Details

### Under Lock-in:
- 7,655 shares (Demat): Lock-in from 15-Dec-2025 to 16-Jun-2027
- 77,640 shares (Physical): Lock-in from 15-Dec-2025 to 16-Jun-2026
- 2,44,36,154 shares (Demat): Lock-in from 15-Dec-2025 to 16-Jun-2027
- 5,13,48,216 shares (Demat): Lock-in from 15-Dec-2025 to 16-Jun-2026
- 18,82,080 shares (Demat): Lock-in from 07-Jul-2025 to 08-Jan-2026
- 18,78,142 shares (Demat): Lock-in from 15-Dec-2025 to 13-Jan-2026
- 17,67,810 shares (Demat): Lock-in from 15-Dec-2025 to 14-Mar-2026

### Not Under Lock-in:
- 28,28,959 shares (Demat): Lock-in not applicable - AIF Category II
- 28,28,960 shares (Demat): Lock-in not applicable - ESOP
- 1,32,85,101 shares (Demat): Lock-in not applicable - IPO Public

## Important Dates

- Listing date: December 16, 2025
- Earliest lock-in expiry: January 8, 2026
- Latest lock-in expiry: June 16, 2027
- Various intermediate lock-in expiry dates: January 13, 2026; March 14, 2026; June 16, 2026

## Compliance Requirements

- Shares under lock-in cannot be traded until respective lock-in periods expire
- Lock-in provisions must be adhered to as per SEBI regulations
- Trading members and investors must verify lock-in status before executing transactions

## Impact Assessment

The listing brings NEPHROCARE HEALTH SERVICES LIMITED to the public markets with a structured lock-in framework. Approximately 86.75% of shares are under various lock-in periods, ensuring controlled supply in the market during initial trading phase. The 13.25% freely tradable shares (including IPO public, ESOP, and AIF allocations) will provide initial liquidity. Gradual unlock of promoter and investor holdings between January 2026 and June 2027 will progressively increase market float.